Sana Biotechnology, Inc. Basic Shares Outstanding (Weighted Average)
Sana Biotechnology, Inc. (SANA) reported Basic Shares Outstanding (Weighted Average) of 295.67 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 295.67M shares, a 24.02% increase year-over-year.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 276.86M shares, a 16.53% increase year-over-year.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 276.20M shares, a 16.87% increase year-over-year.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 260.49M shares, a 10.65% increase year-over-year.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 253.23M shares, a 9.68% increase from fiscal 2024.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 230.89M shares, a 18.69% increase from fiscal 2023.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 194.54M shares, a 3.29% increase from fiscal 2022.
- Sana Biotechnology, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 188.34M shares, a 13.17% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 295.67M shares 10-Q · filed 2026-08-10 | 286.31M shares 10-Q · filed 2026-08-10 | 282.91M shares derived: average of 3 quarters · filed 2026-08-10 | 277.30M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 276.86M shares 10-Q · filed 2026-05-11 | 276.53M shares derived: average of 2 quarters · filed 2026-05-11 | 271.18M shares derived: average of 3 quarters · filed 2026-05-11 | 262.99M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | 276.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 268.35M shares derived: average of 2 quarters · filed 2026-03-03 | 258.37M shares derived: average of 3 quarters · filed 2026-08-10 | 253.23M shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 260.49M shares 10-Q · filed 2025-11-06 | 249.45M shares derived: average of 2 quarters · filed 2026-08-10 | 245.58M shares 10-Q · filed 2025-11-06 | 243.20M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | 238.41M shares 10-Q · filed 2026-08-10 | 238.00M shares 10-Q · filed 2026-08-10 | 237.44M shares derived: average of 3 quarters · filed 2026-08-10 | 236.93M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | 237.58M shares 10-Q · filed 2026-05-11 | 236.96M shares derived: average of 2 quarters · filed 2026-05-11 | 236.44M shares derived: average of 3 quarters · filed 2026-05-11 | 235.94M shares derived: average of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 236.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 235.87M shares derived: average of 2 quarters · filed 2026-03-03 | 235.40M shares derived: average of 3 quarters · filed 2026-03-03 | 230.89M shares 10-K · filed 2026-03-03 |
| 2024-09-30 | 235.41M shares 10-Q · filed 2025-11-06 | 234.93M shares derived: average of 2 quarters · filed 2025-11-06 | 229.08M shares 10-Q · filed 2025-11-06 | 221.12M shares derived: average of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | 234.44M shares 10-Q · filed 2025-08-11 | 225.87M shares 10-Q · filed 2025-08-11 | 216.36M shares derived: average of 3 quarters · filed 2026-03-03 | 211.51M shares derived: average of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | 217.29M shares 10-Q · filed 2025-05-08 | 207.32M shares derived: average of 2 quarters · filed 2026-03-03 | 203.87M shares derived: average of 3 quarters · filed 2026-03-03 | 201.04M shares derived: average of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | 197.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 197.16M shares derived: average of 2 quarters · filed 2026-03-03 | 195.62M shares derived: average of 3 quarters · filed 2026-03-03 | 194.54M shares 10-K · filed 2026-03-03 |
| 2023-09-30 | 196.98M shares 10-Q · filed 2024-11-08 | 194.76M shares derived: average of 2 quarters · filed 2024-11-08 | 193.60M shares 10-Q · filed 2024-11-08 | 192.80M shares derived: average of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | 192.54M shares 10-Q · filed 2024-08-08 | 191.89M shares 10-Q · filed 2024-08-08 | 191.40M shares derived: average of 3 quarters · filed 2025-03-17 | 190.88M shares derived: average of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | 191.23M shares 10-Q · filed 2024-05-08 | 190.83M shares derived: average of 2 quarters · filed 2025-03-17 | 190.32M shares derived: average of 3 quarters · filed 2025-03-17 | 189.65M shares derived: average of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | 190.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 189.87M shares derived: average of 2 quarters · filed 2025-03-17 | 189.12M shares derived: average of 3 quarters · filed 2025-03-17 | 188.34M shares 10-K · filed 2025-03-17 |
| 2022-09-30 | 189.30M shares 10-Q · filed 2023-11-08 | 188.46M shares derived: average of 2 quarters · filed 2023-11-08 | 187.65M shares 10-Q · filed 2023-11-08 | 186.77M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 187.63M shares 10-Q · filed 2023-08-03 | 186.80M shares 10-Q · filed 2023-08-03 | 185.92M shares derived: average of 3 quarters · filed 2024-02-29 | 184.90M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 185.96M shares 10-Q · filed 2023-05-08 | 185.07M shares derived: average of 2 quarters · filed 2024-02-29 | 183.99M shares derived: average of 3 quarters · filed 2024-02-29 | 182.97M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | 184.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 183.01M shares derived: average of 2 quarters · filed 2024-02-29 | 181.97M shares derived: average of 3 quarters · filed 2024-02-29 | 166.43M shares 10-K · filed 2024-02-29 |
| 2021-09-30 | 181.83M shares 10-Q · filed 2022-11-02 | 180.86M shares derived: average of 2 quarters · filed 2022-11-02 | 160.51M shares 10-Q · filed 2022-11-02 | |
| 2021-06-30 | 179.90M shares 10-Q · filed 2022-08-04 | 149.68M shares 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | 13.01M shares 10-K · filed 2023-03-16 | |||
| 2020-06-30 | 12.23M shares 10-Q · filed 2021-08-04 | 11.53M shares 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |